Sun Pharma acquires three anti-inflammation brands from Aksigen

Sun Pharma acquires three anti-inflammation brands from Aksigen Disperzyme and Phlogam are the first enzyme-bioflavonoid combinations of Trypsin, Bromelain and Rutoside to complete a clinical study in India and get DCGI approval. The brands were registered and launched in India by Aksigen in 2013. https://ift.tt/a6l3UCn